Elanco Animal Health (ELAN)
The price, the headline numbers and the latest news, in one place.
Elanco Animal Health (ELAN) Stock Price, Analysis & Data
No data available
| Bid | 0 |
| Market Cap | 11.8B |
| Revenue (ttm) | 5.02B |
| Net Income (ttm) | -199M |
| 1.68 | |
| -0.4 | |
| n/a | |
| 18.4 | |
| P/B (ttm) | 1.79 |
| P/S (ttm) | 2.34 |
| Earnings Date | Nov 5, 2026 |
| Ask | 0 |
| Volume | 3,881,157 |
| Avg. Volume (20D) | 5,949,285 |
| Open | 23.91 |
| Previous Close | 23.97 |
| Day's Range | 23.50 - 23.95 |
| 52-Week Range | 18.22 - 27.98 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ELAN
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the pr...
Financial Performance
In 2025, Elanco Animal Health's revenue was 4.72B, an increase of 6.22% compared to the previous year's 4.44B. Earnings were -232M, a decrease of -168.64%.
Financial StatementsEarnings Surprise
- Revenue of $1.37B misses estimates by $0, with 10.23% YoY growth.
- EPS of 0.34 exceeds estimates by 0.07, with 30.77% YoY growth.
Analysts project revenue of ... Upgrade
2 weeks ago · St. Joseph News-Press, Mo.
Elanco celebrates $120 million expansion of Elwood manufacturing facilityELWOOD, Kan. (News-Press NOW) — Elanco Animal Health recently completed a $120 million expansion of its Elwood manufacturing facility, quadrupling production capacity at a site that company leaders sa...
